首页> 外文期刊>Clinical and Translational Allergy >Formula supplementation of breast-fed infants increases the incidence of cow’s milk protein allergy
【24h】

Formula supplementation of breast-fed infants increases the incidence of cow’s milk protein allergy

机译:母乳喂养婴儿的配方奶粉增加了牛奶蛋白过敏的发生率

获取原文
           

摘要

AimOne motivation for breast feeding is to prevent allergicdisease in infants. Many breast fed babies in Irelandreceive formula supplementation, within 24 hours ofbirth, though there are few medical indications for this.We explored (i) impact of upplementation on the likelihoodof developing Cow’s Milk Protein Allergy (CMPA),and (ii) current practice of formula supplementation(<24h) among mothers intending to breast feed.Method55 CMPA-diagnosed children, with 3 feed type levels(breast only; formula only; breast with formula supplementation)and 55 non allergic, age and sex matched controls(born 2010-2011) were identified retrospectively inCork University Maternity Hospital. Logistic regression(LoR) examined formula supplementation on likelihood ofdeveloping CMPA. Formula supplementation was prospectivelymeasured among a separate group of 179breast-feeding mothers. Linear regression (LiR) analysiswas used to examine reasons and pre-existing factors forsupplementation.Results(i) LoR examined which feed type predicted developmentof CMPA. The model, controlling for parentalatopy and infant sex, showed only formula supplementationwas significant, (c2 (3) = 25.74, p < 0.05) with 74%diagnostic accuracy. Infants given top-up formula were7.03 (95% CI, 1.82 - 27.25) times more likely to exhibitCMPA than those who were breast-fed only.(ii) Frequency of current formula supplementation inbreast fed infants (<24h) is 45.8%, with 56% administeredby mother. LiR examined whether reasons for supplementationpredicted development of CMPA. This model(incl. nurse advice and maternal/infant perceived wellbeing)was significant (F(8,170)=66.95, p<0.05) with 75%accuracy. In relation to pre-existing factors, only type ofdelivery predicted whether a mother would supplementwith formula.ConclusionFormula supplementation of breast fed babies in thefirst 24h is rarely medically indicated and is stronglyassociated with an increased risk of developing CMPA.The impact of professional advice is important. Attentionshould be given to measures aimed at reducing thispotentially harmful practice.
机译:AimOne母乳喂养的动机是防止婴儿过敏性疾病。爱尔兰的许多母乳喂养婴儿在出生后24小时内就接受了配方奶粉补充,尽管对此没有什么医学适应症。我们探讨了(i)补充奶粉对发展牛乳蛋白过敏(CMPA)的可能性的影响,以及(ii)目前的做法方法55 CMPA诊断的儿童,具有3种饲料类型水平(仅母乳;仅配方奶;具有配方奶的母乳)和55位非过敏,年龄和性别相匹配的对照组(2010年出生,2010年出生) 2011年)在美国科克大学妇产科医院进行回顾性鉴定。 Logistic回归(LoR)检查了补充CMPA可能性的公式。在另外一组179名母乳喂养母亲中前瞻性地测量了配方奶的添加量。结果:(i)LoR检查了哪种饲料类型预测了CMPA的发展。控制肠胃外和婴儿性别的模型显示只有配方奶粉才有意义(c2(3)= 25.74,p <0.05),诊断准确性为74%。母乳喂养婴儿的CMPA发生率比仅母乳喂养婴儿高7.03倍(95%CI,1.82-27.25)。(ii)当前母乳喂养婴儿(<24h)的补充奶粉频率为45.8%。 ,其中56%由母亲管理。 LiR检查了补充的原因是否可以预测CMPA的发展。这个模型(包括护士的建议和母婴的感觉良好)非常显着(F(8,170)= 66.95,p <0.05),准确率达75%。关于先前存在的因素,只有分娩的类型才能预测母亲是否会补充配方奶。结论医学上很少有人指出在头24小时内对母乳喂养婴儿进行配方补充,这与患CMPA的风险增加密切相关。专业建议的影响很重要。应注意旨在减少这种潜在有害做法的措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号